{
    "organizations": [],
    "uuid": "588a40e28a551a428aa750b1ad018e7ca0e16612",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-inventiva-announces-positive-outco/brief-inventiva-announces-positive-outcomes-of-biomarker-study-idUSFWN1QG15H",
    "ord_in_thread": 0,
    "title": "BRIEF-Inventiva Announces Positive Outcomes Of Biomarker Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - INVENTIVA SA:\n* INVENTIVA ANNOUNCES POSITIVE OUTCOMES OF BIOMARKER STUDY MEASURING INTRACELLULAR GAGS IN LEUKOCYTES FROM MPS VI PATIENTS\n* ‍DATA CONFIRM HIGHLY PROMISING BIOMARKER FOR MPS VI AND LIMITED ENZYME REPLACEMENT THERAPY (ERT) EFFICACY IN REDUCING LEUKOGAGS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-27T01:08:00.000+02:00",
    "crawled": "2018-02-27T14:55:59.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "inventiva",
        "sa",
        "inventiva",
        "announces",
        "positive",
        "outcome",
        "biomarker",
        "study",
        "measuring",
        "intracellular",
        "gag",
        "leukocyte",
        "mp",
        "vi",
        "patient",
        "confirm",
        "highly",
        "promising",
        "biomarker",
        "mp",
        "vi",
        "limited",
        "enzyme",
        "replacement",
        "therapy",
        "ert",
        "efficacy",
        "reducing",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}